Dataminr commissioned Economist Impact to examine global businesses’ value creation
and resilience priorities via a survey of 600 executives across six industries. In this industry profile, we take a closer look at survey findings from respondents in the pharmaceutical industry.
Read the profile to learn how pharmaceutical companies are: